The University of Chicago Header Logo

Connection

Bruce Bauer to Neurocutaneous Syndromes

Back to Details
This is a "connection" page, showing publications Bruce Bauer has written about Neurocutaneous Syndromes.
Bruce Bauer
Connection Strength
0.171
Neurocutaneous Syndromes
  1. The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis. Cancer Genomics Proteomics. 2018 Jul-Aug; 15(4):239-248.
    View in: PubMed
    Score: 0.143
  2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Pediatr Dev Pathol. 2015 Jan-Feb; 18(1):1-9.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.